Azitra, Inc. (NYSEAMERICAN:AZTR) Shares Shorted: Short Interest Down 53.4% in October

Azitra, Inc. (NYSEAMERICAN:AZTR) was the target of a significant decrease in short interest during the month of October. As of October 15th, there was short interest totaling 112,293 shares, a decrease of 53.4% from the September 30th total of 240,809 shares. Based on an average daily volume of 667,182 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.2% of the shares of the company are short sold.

Azitra Price Performance

Shares of NYSEAMERICAN AZTR traded up $0.01 during mid-day trading on Friday, hitting $0.77. 782,984 shares of the company were exchanged, compared to its average volume of 8,033,131. The stock has a 50 day simple moving average of $1.90 and a 200-day simple moving average of $1.96. Azitra has a 1-year low of $0.52 and a 1-year high of $5.59.

Azitra (NYSEAMERICAN:AZTR) last posted its quarterly earnings data on Wednesday, August 12th. The company reported ($1.70) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.15) by ($0.55). Sell-side analysts forecast that Azitra will post -2.00 EPS for the current year.

Azitra Company Profile

Azitra, Inc is a clinical-stage biotechnology company focused on developing microbiome-based therapies for dermatological conditions. The company combines microbiology, genetic engineering and computational tools to identify and develop targeted treatments intended to address diseases affecting the skin.

Azitra’s platform centers on engineered strains of beneficial skin bacteria and biologic compounds designed to deliver therapeutic proteins or otherwise influence the skin’s local environment.